Details of the Drug
General Information of Drug (ID: DM19FS3)
| Drug Name |
Norzimelidine
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Norzimeldine; 3-(4-Bromophenyl)-N-methyl-3-(3-pyridinyl)-2-propen-1-amine; 2-Propen-1-amine, 3-(4-bromophenyl)-N-methyl-3-(3-pyridinyl)-; cholesterol-3-glucose; AC1O5OK9; CHEMBL173745; SCHEMBL11636758; 60324-58-5; LS-175771; A-23889; 3-(4-bromophenyl)-N-methyl-(3-pyiidyl)allylamine oxalate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 303.2 | ||||
| Logarithm of the Partition Coefficient (xlogp) | 3.4 | |||||
| Rotatable Bond Count (rotbonds) | 4 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||
| Chemical Identifiers |
|
|||||
| Cross-matching ID | ||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


